Citation Impact
Citing Papers
Short Preoperative Treatment With Erlotinib Inhibits Tumor Cell Proliferation in Hormone Receptor–Positive Breast Cancers
2008
PAD4 is essential for antibacterial innate immunity mediated by neutrophil extracellular traps
2010 Standout
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
Wild-Type KRAS Is Required for Panitumumab Efficacy in Patients With Metastatic Colorectal Cancer
2008 Standout
G-CSF and GM-CSF for treating or preventing neonatal infections
2003
Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock
2004 Standout
Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group
2007 Standout
EGFR Antagonists in Cancer Treatment
2008 Standout
Inflammation in preterm and term labour and delivery
2006 Standout
Circulating soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) as diagnostic and prognostic marker in neonatal sepsis
2013 Standout
Pancreatic cancer
2004 Standout
Enzymatic Targeting of the Stroma Ablates Physical Barriers to Treatment of Pancreatic Ductal Adenocarcinoma
2012 Standout
The Human Intestinal Microbiome in Health and Disease
2016 Standout
Structure‐activity relationships of α‐conotoxins targeting neuronal nicotinic acetylcholine receptors
2004
Pancreatic cancer
2016 Standout
Macrolides sensitize EGFR-TKI-induced non-apoptotic cell death via blocking autophagy flux in pancreatic cancer cell lines
2015 StandoutNobel
Pancreatic Adenocarcinoma
2014 Standout
Natural products to drugs: natural product-derived compounds in clinical trials
2008 Standout
Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer
2007 Standout
Differences in the fetal interleukin-6 response to microbial invasion of the amniotic cavity between term and preterm gestation
2003
The immune consequences of preterm birth
2013
The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition
2016 Standout
VEGF-targeted therapy: mechanisms of anti-tumour activity
2008 Standout
Galantamine Prolonged-Release Formulation in the Treatment of Mild to Moderate Alzheimer’s Disease
2005
Neutrophils, from Marrow to Microbes
2010 Standout
A review on emerging contaminants in wastewaters and the environment: Current knowledge, understudied areas and recommendations for future monitoring
2014 Standout
Innate immunity of the newborn: basic mechanisms and clinical correlates
2007 Standout
Pancreatic Cancer
2010 Standout
Guidelines for the use of platelet transfusions
2016
Targeting PI3K signalling in cancer: opportunities, challenges and limitations
2009 Standout
Neutrophil Production and Function in Newborn Infants
2000
Phagocytic ability of neutrophils and monocytes in neonates
2011
Pancreatic cancer
2011 Standout
Intracellular staphylococcus aureus: Live-in and let die
2012
Extracellular DNA traps promote thrombosis
2010 Standout
Neutrophil adhesion molecules in term and premature infants: normal or enhanced leucocyte integrins but defective L-selectin expression and shedding
1995
Antiangiogenic and Antitumor Effects of Bevacizumab in Patients With Inflammatory and Locally Advanced Breast Cancer
2006
Fluorine and Fluorinated Motifs in the Design and Application of Bioisosteres for Drug Design
2018 Standout
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
2011 Standout
Critical Update and Emerging Trends in Epidermal Growth Factor Receptor Targeting in Cancer
2005
Neutrophil and endothelial adhesive function during human fetal ontogeny
2012
Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock
2004 Standout
A Novel Mechanism of Rapid Nuclear Neutrophil Extracellular Trap Formation in Response to Staphylococcus aureus
2010 Standout
Maturation of the enteric mucosal innate immune system during the postnatal period
2014
Evolution of the immune system in humans from infancy to old age
2015 Standout
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
Interaction of Neonatal Phagocytes with Group B Streptococcus: Recognition and Response
2006
Update on rifampin, rifabutin, and rifapentine drug interactions
2012
Neutrophil Function in Preterm and Term Infants
2004
Bevacizumab Plus Irinotecan in Recurrent Glioblastoma Multiforme
2007 Standout
A mini-review on platelet refractoriness.
2005
A Randomized Trial of Granulocyte-Macrophage Colony-Stimulating Factor in Neonates With Sepsis and Neutropenia
2001
Impaired neutrophil extracellular trap (NET) formation: a novel innate immune deficiency of human neonates
2009
Improving Drug Design: An Update on Recent Applications of Efficiency Metrics, Strategies for Replacing Problematic Elements, and Compounds in Nontraditional Drug Space
2016
Antimicrobial Resistance in ESKAPE Pathogens
2020 Standout
Cholinesterase inhibitors for Alzheimer's disease
2006 Standout
Stereospecific pharmacokinetics and pharmacodynamics of beta-adrenergic blockers in humans.
2001
Works of Robert A. Carr being referenced
Audit of Practice in Platelet Refractoriness
1997
Impaired Neutrophil Phagocytosis in Preterm Neonates: Lack of Correlation with Expression of Immunoglobulin or Complement Receptors
1995
Nicotinic receptor modulation: Advantages for successful Alzheimer’s disease therapy
2002
Stereospeciflc High-Performance Liquid Chromatographic Assay of Sotalol in Plasma
1991
Haemopoietic growth factors for neonates: assessing risks and benefits
2004
Dual Effects of Rifampin on the Pharmacokinetics of Atrasentan
2007
Protein binding of sotalol enantiomers in young and elderly human and rat serum using ultrafiltration
1995
Changes in Plasma FcRIII Demonstrate Increasing Receptor Production during Late Pregnancy and after Preterm Birth
1992
Haemopoietic colony stimulating factors for preterm neonates
1997
A Win–Win Solution in Oral Delivery of Lipophilic Drugs: Supersaturation via Amorphous Solid Dispersions Increases Apparent Solubility without Sacrifice of Intestinal Membrane Permeability
2012
Pharmacokinetics (PK) of the angiogenesis inhibitor ABT-510 in healthy subjects
2004
Abnormal FcRIII expression by neutrophils from very preterm neonates
1990
Neutrophil chemotaxis and adhesion in preterm babies.
1992